Volume : VIII, Issue : I, January - 2018

Efficacy, Predictability and Safety of Epithelial Laser In–Situ Keratomileusis (Epi–LASIK) in myopia.

Kshama Popat

Abstract :

 

AIM: To study visual and refractive outcomes of Epi–LASIK in moderate myopia with Spherical Equivalent (SE) between –4.5 to –7.0 D (diopters).

METHODS: Retrospective, interventional study of 68 eyes of 39 patients, who had Epi–LASIK with Mitomycin C (MMC), in which primary outcome variables studied were uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), haze and regression.

RESULTS: Preoperatively, mean SE was –5.79±0.50. At 1 year final visit, mean SE was –0.03±0.10, 85.9% eyes achieved UCVA of 20/20, 7.6% achieved 20/25, 3.8% achieved 20/30, 2.7% achieved 20/40. BCVA of 2 eyes was 20/30 and 1 eye 20/40. 62 eyes were within ±0.75 D of attempted correction. 4 eyes had trace haze, 2 had grade 1 haze and 1 grade 2 haze. 6 eyes had regression of myopia ≥ –0.75 D.  

CONCLUSION: Epi–LASIK is safe, effective and predictable method for the treatment of moderate myopia.

 

Keywords :

Article: Download PDF   DOI : 10.36106/ijar  

Cite This Article:

Kshama Popat, Efficacy, Predictability and Safety of Epithelial Laser In–Situ Keratomileusis (Epi–LASIK) in myopia., INDIAN JOURNAL OF APPLIED RESEARCH : Volume-8 | Issue-1 | January-2018

Number of Downloads : 247

References :